Table 2.
Change in AST, ALT, creatinine, urates, PT, and INR within control and AG intervention groups.
| Parameter | Control group (n = 39) | Δ (%) | Intervention group (n = 35) | Δ (%) | ||
|---|---|---|---|---|---|---|
| Week 0 | Week 12 | Week 0 | Week 12 | |||
| AST (U/L) | 21.1 ± 7.46 | 20.9 ± 7.02 | 0.26 (1.23) | 19.6 ± 6.73 | 18.3 ± 4.17 | 1.32 (6.74) |
| ALT (U/L) | 24.7 ± 10.95 | 24.7 ± 11.66 | −0.04 (−0.16) | 25.5 ± 12.67 | 23.9 ± 10.25 | 1.65 (6.47) |
| Creatinine (μmol/L) | 83.78 ± 18.97 | 85.0 ± 15.47 | −1.28 (−1.49) | 82.3 ± 15.85 | 84.1 ± 15.49 | −1.74 (−2.11) |
| Urates (μmol/L) | 309.7 ± 68.21 | 294.8 ± 79.26 | 14.9 (4.8) | 314.1 ± 82.27 | 311.9 ± 87.49 | 2.2 (0.7) |
| PT | 100.3 ± 11.53 | 101.2 ± 10.78 | −0.93 (−0.93) | 98.1 ± 8.54 | 98.7 ± 9.35 | −0.58 (−0.59) |
| INR | 0.9 ± 0.08 | 1.0 ± 0.07 | −0.01 (−1.01) | 1.0 ± 0.08 | 0.9 ± 0.05 | 0.04 (3.96) |
Data expressed as mean ± SD.